Clinical experience with 20 cases of group streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997

Plastic and Reconstructive Surgery

Volumn 103, Issue 6, 1999, Pages 1567-1573

  Haywood, Catherine T ^b   McGeer, Allison ^b   Low, Donald E ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; BODY DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MALE; MORTALITY; MUSCLE NECROSIS; NECROTIZING FASCIITIS; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0033005276     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199905000-00003     Document Type: Article

References (24)

1. Loudon, I. Necrotising fasciitis, hospital gangrene, and phagedena. Lancet 344: 1416, 1994.
2. Meleney, F. L. Hemolytic streptococcus gangrene. Arch. Surg. 9: 317, 1924.
3. Davies, H. D., McGeer, A., Schwartz, B., et al. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335: 547, 1996.
4. Demers, B., Simor, A. E., Vellend, H., et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin. Infect. Dis. 16: 792, 1993.
5. Bisno, A. L., and Stevens, D. L. Streptococcal infections of skin and soft tissues. N. Engl. J. Med. 334: 240, 1996.
6. Wood, T. F., Potter, M. A., and Jonasson, O. Streptococcal toxic shock-like syndrome: The importance of surgical intervention. Ann. Surg. 217: 109, 1993.
7. Ward, R. G., and Walsh, M. S. Necrotising fasciitis: 10 years' experience in a district general hospital. Br. J. Surg. 78: 488, 1991.
8. Kiska, D. L., Thiede, B., Caracciolo, J., et al. Invasive group A streptococcal infections in North Carolina: Epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J. Infect. Dis. 176: 992, 1997.
9. Kaul, R., McGeer, A., Norrby-Teglund, A., et al. Intravenous immunoglobulin therapy in streptococcal toxic shock syndrome: A comparative observational study. Clin. Infect. Dis. (in press).
10. Norrby-Teglund, A., Kaul, R., Low, D. E., et al. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific G. Infect. Immun. 64: 5395, 1996.
11. Norrby-Teglund, A., Kaul, R., Low, D. E., et al. Plasma from patients with severe group A streptococcal infections treated with normal polyspecific IgG (IVIG) inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J. Immunol. 156: 3057, 1996.
12. Symmers, D., and Lewis, K. M. The antitoxin treatment of erysipelas: Further observations. J.A.M.A 99: 1082, 1932.
13. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition. J.A.M.A. 269: 390, 1993.
14. Facklam, R. R., and Washington, J. A. Manual of Clinical Microbiology. Washington, D.C.: American Society for Microbiology, 1991. Pp. 238-257.
15. Musser, J. M., Gray, B. M., Schlievert, P. M., et al. Streptococcus pyogenes pharyngitis: Characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing. J. Clin. Microbiol. 30: 600, 1992.
16. Swift, H. F., Wilson, A. T., and Lancefield, R. C. Typing group A hemolytic streptococci by M precipitin reactions in capillary pipettes. J. Exp. Med. 78: 127, 1943.
17. Kaul, R., McGeer, A., Low, D. E., et al. Population-based surveillance for group A streptococcal necrotizing tasciitis: Clinical features, prognostic indicators and microbiologic analysis of 77 cases. Am. J. Med. 103: 18, 1997.
18. Cartwright, K., Logan, M., McNulty, C., et al. A cluster of cases of streptococcal necrotising fasciitis in Gloucestershire. Epidemiol. Infect. 115: 387, 1995.
19. Chelsom, J., Halstensen, A., Haga, T., et al. Necrotising fasciitis due to group A streptococci in western Norway: Incidence and clinical features. Lancet 344: 1111, 1994.
20. Gonzales-Ruiz, A., Ridgway, G. L., Cohen, S. L., et al. Varicella gangrenosa with toxic shock-like syndrome due to group A streptococcus infection in an adult: Case report. Clin. Infect. Dis. 20: 1058, 1995.
21. Adams, E. M., Gudmundsson, S., Yocum, D. E., et al. Streptococcal myositis. Arch. Intern. Med. 145: 1020, 1985.
22. Stevens, D. L. Invasive group A streptococcus infections. Clin. Infect. Dis. 14: 2, 1992.
23. Lukomski, S., Sreevatsan, S., Amberg, C., et al. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Invest. 99: 2574, 1997.
24. Viard, I., Wehrli, P., Bullani, R., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282: 490, 1998.